Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.450
-0.210 (-4.51%)
Apr 16, 2026, 4:08 PM HKT

HKG:2576 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
512.54551.16573.14549.22466.18
Revenue Growth (YoY)
-7.01%-3.84%4.36%17.81%53.88%
Cost of Revenue
295326.21394.14363.81301.85
Gross Profit
217.54224.94179185.4164.33
Selling, General & Admin
202.01408.99419.12473.79446.23
Research & Development
78.6787.05169.19208.18190.84
Other Operating Expenses
-7.22-9.64-16.24-15.69-13.56
Operating Expenses
273.45489.99580.4670.84626.92
Operating Income
-55.91-265.05-401.4-485.44-462.59
Interest Expense
-0.83-0.73-1.43-2.68-2.71
Interest & Investment Income
35.6537.0541.6522.8828.74
Currency Exchange Gain (Loss)
-29.617.488.6554.03-7.96
Other Non Operating Income (Expenses)
---1.27-0.82
EBT Excluding Unusual Items
-50.7-211.25-352.53-409.94-445.33
Impairment of Goodwill
--9.8-8.37-22.38-54.09
Gain (Loss) on Sale of Investments
-3.765.849.7919.8
Gain (Loss) on Sale of Assets
--0.17--0.470.02
Asset Writedown
---1.2--
Other Unusual Items
-0.04-0.110.42-
Pretax Income
-50.7-217.41-356.36-422.58-479.61
Income Tax Expense
--0.02-0.01
Earnings From Continuing Operations
-50.7-217.41-356.38-422.58-479.61
Minority Interest in Earnings
7.862.89.69.67-
Net Income
-42.85-214.61-346.78-412.91-479.61
Net Income to Common
-42.85-214.61-346.78-412.91-479.61
Shares Outstanding (Basic)
564544538538538
Shares Outstanding (Diluted)
564544538538538
Shares Change (YoY)
3.65%1.10%--15.22%
EPS (Basic)
-0.08-0.39-0.64-0.77-0.89
EPS (Diluted)
-0.08-0.39-0.64-0.77-0.89
Free Cash Flow
--207.3-355.52-353.62-247.63
Free Cash Flow Per Share
--0.38-0.66-0.66-0.46
Gross Margin
42.44%40.81%31.23%33.76%35.25%
Operating Margin
-10.91%-48.09%-70.04%-88.39%-99.23%
Profit Margin
-8.36%-38.94%-60.50%-75.18%-102.88%
Free Cash Flow Margin
--37.61%-62.03%-64.39%-53.12%
EBITDA
-39.53-248.66-378.66-463.41-451.58
EBITDA Margin
-7.71%-45.12%-66.07%-84.38%-96.87%
D&A For EBITDA
16.3916.3922.7422.0311
EBIT
-55.91-265.05-401.4-485.44-462.59
EBIT Margin
-10.91%-48.09%-70.04%-88.39%-99.23%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.